Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Journal of Controlled Release, 336 , 310-321
Unlike tesamorelin, ipamorelin has not been approved by the FDA for any use, and has yet to be reviewed in human clinical trials
Dosage can be gradually increased as tolerated to achieve the desired effects
The peptide is metabolized and cleared relatively quickly, which also means it does not accumulate in your system the way some longer-acting compounds might
CJC-1295 without DAC is a short-acting GHRH analog which, in the published pharmacological data, is described as a molecule with a short half-life and a fast, pulsatile profile of action on the GH axis
Due to the formidable barrier posed by the SC, only a limited number of drugs are approved for transdermal delivery [228, 229]
US$ 26.39
US$ 24.61
US$ 20.71
US$ 21.84
US$ 26.02
US$ 27.72
US$ 22.45
US$ 24.17
